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The resurgence of tuberculosis around the world has renewed interest in understanding the
epidemiology and pathogenesis of this disease. A revolutionary advance in the field of
tuberculosis research has been the development of molecular techniques that permit
identification and tracking of individual strains of Mycobacterium tuberculosis. With these
techniques, molecular epidemiology has been established as a new discipline that adds another
dimension to the classical epidemiology of tuberculosis and has increased our understanding
of the transmission dynamics of M. tuberculosis. The increased epidemiological knowledge has
led to discovery of inadequacies in tuberculosis control programs; this information has helped
garner resources for program improvement and has highlighted the need for the continuous
surveillance of tuberculosis. Additional genetic methods are being developed based on the
knowledge of the genome sequence of M. tuberculosis. These simpler and less costly genotyping
techniques promise to expand the application of molecular epidemiology to developing nations
(where 90% of the disease burden occurs) in support of national tuberculosis programs.
Furthermore, these tools permit ever more effective probes into the dynamics of transmission,
the population structure, evolution and pathogenesis of M. tuberculosis.
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Epidemiología molecular de la tuberculosis: métodos y aplicaciones
La reemergencia de la tuberculosis en el mundo ha despertado el interés en el entendimiento
de la epidemiología y patogénesis de esta enfermedad. Un revolucionario avance en este
campo de investigación ha sido el desarrollo de técnicas moleculares que permiten identificar
y establecer la huella particular de cada cepa de M. tuberculosis. Con el uso de estas técnicas,
y el establecimiento de la epidemilogia molecular como nueva disciplina se adicionó otra
dimensión a la epidemiologia clásica de la tuberculosis y ha incrementado el conocimiento de
la dinámica de la transmisión de M. tuberculosis  dentro de una población. En el proceso han
sido identificados problemas en los programas de control, lo cual ha ayudado a obtener recursos
para su mejoramineto e implementación. Aún más, se ha resaltado la necesidad de continuar
vigilando esta enfermedad. Otras metodologías genotípicas han sido desarrolladas a partir del
conocimiento de la secuencia del genoma de M. tuberculosis. Estas metodologías genotípicas
de fácil implementación y bajo costo se deben aplicar en países en vía de desarrollo, donde
existe el 90% de la enfermedad, como apoyo a los programas de control de la tuberculosis.
Estas herramientas permitirán conocer la dinámica de transmisión de la tuberculosis, la
estructura de la población, la evolución y patogénesis de M. tuberculosis.
Palabras clave: tuberculosis, Mycobacterium tuberculosis/patogenicidad/efecto de drogas,
epidemiología molecular, genotipo, huella de ADN/métodos, polimorfismo de longitud del
fragmento de restricción.
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Genotyping methods
With the arrival of the genomics era, the ideal
method, in principle, to access genetic variability
between strains is the comparison of entire indi-
vidual genome sequences among Mycobacterium
tuberculosis strains (1). However, assessment of
whole genomic variability among strains requires
bioinformatics expertise, time, and economical
resources. These limitations allow us only to in-
terrogate a fraction of the genome to obtain geno-
types with sufficient variability to discriminate
among different strains. This approach permits a
rapid interpretation of the patterns obtained and is
not time consuming. For example, the standard-
ization and application of molecular epidemiology
techniques with the insertion sequence IS6110
restriction fragment length polymorphism (RFLP)
has brought a new dimension to the study of tu-
berculosis and with it, a new appreciation of the
bacterial ecological complexities within populations
that classical epidemiology could not provide. The
IS6110 RFLP technique is the most extensively
applied and studied method, but is labor intensive
and expensive when compared to the newer PCR
(polymerase chain reaction) based molecular
epidemiology techniques. In addition, the ease of
access to the M. tuberculosis genome sequence
has led to the recognition of more than 30 other
repetitive elements, which promise to be useful
as typing methods (2). In this review we will briefly
discuss the most commonly used genotyping
methods.
IS6110 RFLP
This insertion sequence is mostly present in the
M. tuberculosis complex species. The number of
copies of IS6110 differs from 0 to over 25 and
their insertion position in the M. tuberculosis
genome is variable between different strains (3).
However, IS6110 sequences are non-randomly
distributed, suggesting preferential integration re-
gions or insertional hot spots. One of these is an
area flanked by a directly repeated (DR) sequence
(4). This variability is sufficient to generate poly-
morphism and serves as the basis for differenti-
ating between strains. This non-random distribu-
tion of IS6110 within the genome and the low copy
number of some strains depending on geographic
region is recognized as a limitation to the discrimi-
native power of this methodology and its broad
application (5).
The IS6110 insertion sequence based typing is
the gold standard to which other techniques are
presently evaluated; this technique has been
standardized and is widely used. A variety of
factors were recognized for the standardization of
M. tuberculosis genotyping. For example, the use
of a unique restriction enzyme for DNA digestion,
and the inclusion of molecular standards to
estimate band sizes (6). Consequently this
standarization of IS6110 RFLP is now extensively
applied in the genotyping investigations of M.
tuberculosis (7-11).  This standardization has made
possible the comparison of genotypes performed
in different laboratories around the world, allowing
the global dispersal of strains to be tracked. For
example, an HIV seropositive patient developed
primary tuberculosis with a multidrug resistant
(MDR) strain in San Francisco. This patient had
been hospitalized in Buenos Aires, Argentina, the
previous year, during the time of a reported large
outbreak of MDR-TB (12). The San Francisco strain
was found to have exactly the same IS6110-RFLP
pattern and antibiotic resistance profile as the
Buenos Aires strains (M. Burgos, unpublished
data). This transnational spread demonstrates the
geographic extent to which individual strains of
M. tuberculosis can be disseminated.
Population based molecular epidemiological
studies report that most strains have between 8
to 18 copies of the IS6110 insertion element each,
a number that is adequate to allow discrimination
between the majority of strains. However, there
are geographical areas in Asia and Africa where
the diversity of IS6110 is considerably reduced
(13-15). In San Francisco, out of 1800 patients
during a period of 9 years, 1117 (62.2%) had
distinct genotypes and 683 (37.9%) were in 171
clusters sharing identical patterns (more than 5
bands). In some parts of Asia and Africa the lack
of polymorphism linked with low copy numbers
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limits the epidemiological inferences that can be
drawn from the use of this genotypic method.
However, other secondary typing methods could
help discriminate between strains with few IS6110
copies (16-20).
Understanding the rates at which IS6110 patterns
change is important for optimal interpretation of
fingerprints in molecular epidemiology studies
taking into account that a group of strains may be
identical for reasons other than recent
transmission, depending on the stability of the
marker. For example, if the IS6110 pattern
changes too rapidly, the number of false negative
epidemiological links will tend to increase and if
the marker is too stable the number of false positive
links will tend to decrease. Thus, markers that
change too rapidly will underestimate the number
of true epidemiological links while markers that
change too slowly will tend to overestimate the
number of true epidemiological links. For instance,
Yeh et al. found that the banding patterns of serial
isolates collected at least 90 days apart from the
same patient, were different in 29% of cases (21).
In this study, changes in IS6110 genotypes were
confined to strains with 8-14 bands and the rate
of change suggested that the number of
epidemiological links were underestimating recent
transmission. However it is possible that studies
involving serial secretors overestimate the rate of
change of IS6110 patterns, because replication
within a host (growth of the mycobacteria) can
provoke IS6110 transposition (10). Nonetheless,
serial passage of strains in vitro, such as for BCG,
has not been associated with such rapid change
of RFLP genotypes (22). On the other hand, in the
Netherlands, the half-life of change of IS6110 was
estimated to be 3.2 years (23). In this study the
rate of change of IS6110 supports the use of this
genotype in studies of recent transmission of
tuberculosis.
PGRS RFLP
The polymorphic GC-rich repetitive sequence
(PGRS) is present in multiple chromosomal
clusters allowing its use as a second RFLP typing
method (19,24,25). This method has a
discriminatory power resembling that of IS6110
typing, even in isolates with low copy numbers of
IS6110 (26). However, PGRS is comprised of
many non-perfect repeats making the RFLP
patterns complex and their interpretation difficult.
As with IS6110, this method requires viable
cultures and large quantities of DNA, which makes
it too labor intensive for epidemiological
investigations.
Simpler, more rapid, less expensive typing meth-
ods than the IS6110 RFLP genotype are neces-
sary in order to study transmission of M. tubercu-
losis in countries with high burden of tuberculosis
disease. In consequence faster methods that are
PCR based have been developed. In this review
we will go over the PCR based genotyping mark-
ers most extensively used and those methods that
show potential for the study of molecular epide-
miology in a global scale.
PCR based genotyping
Large-scale genotyping of M. tuberculosis is not
possible because the existing typing methods are
labor-intensive, difficult to analyze and their
results are often not comparable among
laboratories. In addition as mentioned previously,
the use of IS6110 and PGRS RFLP are hindered
by the need of M. tuberculosis cultures. In contrast,
PCR based methods do not require bacterial
culture and small amounts of DNA can be obtained
in some cases directly from clinical specimens
(27,28). Significantly, some of these PCR methods
can be interpreted in a binary or digital manner,
which makes these typing methods very
convenient for standardization and user friendly
for analysis when making comparisons among
databases from different geographical
regions(16,29,30). These methods have the
potential to expand the application of molecular
epidemiology tools in countries with high burden
of disease.
Spoligotyping
The spoligotyping method is a PCR technique
based on a major polymorphic tandem direct repeat
(DR) sequence in the M. tuberculosis genome (31).
This DR region in M. tuberculosis complex strains
is composed of multiple direct variant repeats
(DVRs), each of which consist of a repetitive 36
base pair element and a short non-repetitive se-
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quence (spacer) (32,33). Using a set of primers
targeting the direct repeat sequences, it is pos-
sible to amplify simultaneously all the region, in-
cluding the unique non-repetitive sequences, or
spacers, located among the direct repeats. The
presence or absence of the spacers is then deter-
mined by using reverse hybridization. Individual
strains are distinguished by the number of spac-
ers absent from a complete spacer set that has
been defined by sequencing this region from M.
tuberculosis strain H37Rv and Mycobacterium
bovis BCG.
Spoligotyping is widely used due to its low cost,
high reproducibility and simplicity (34). This method
is also very easy to interpret because of its binary
result format and useful when comparing data
bases from different geographical regions (17). In
addition, atypical mycobacteria do not give a signal
with spoligotyping, which indicates the specificity
of this technique for the species within the M.
tuberculosis complex (35). This methodology has
been demonstrated to be useful in discriminating
between isolates of M. tuberculosis with few
IS6110 bands (36-38). Another advantage of this
secondary marker is that it is economical and easy
to perform. Spoligotyping is a rapid and efficient
way of fingerprinting the Mycobacterium
tuberculosis complex. Spoligotyping can be
performed directly on sputum samples, which
makes it practical in acute clinical settings (33).
These characteristics make spoligotyping a
candidate for use in countries with high burden of
tuberculosis disease. However, the discriminatory
power of this method is lower than IS6110 typing
and varies depending on the geographical area of
the study (26,39,40).
Variable numbers of tandem repeats
A more promising approach for developing a PCR
based typing system is to identify novel
polymorphic loci, which are independent of
existing techniques such as IS6110 typing.
Automated genotyping based on variable-number
tandem repeats (VNTR) of genetic elements
named mycobacterial interspersed repetitive units
(MIRU) is an example of such methods (41-43).
MIRUs are a specific class of VNTR, identified at
41 distinctive loci in the genome of M. tuberculosis.
Each MIRU encompasses strings of short
repetitive sequences and the number of repeats
varies among strains. PCR amplification across
each MIRU generates fragments of different sizes
for different strains, and the number of repeats at
each locus can be determined. Analysis of a
blinded reference set of 90 strains from 38 coun-
tries established that this method is 100% repro-
ducible, sensitive, and specific for M. tuberculo-
sis complex isolates(26). This performance has
not been achieved by any other typing method
tested in the same conditions. This type of ap-
proach is for the most part adapted to global da-
tabases as each typed strain has been assigned
a 12 digit number matching the number of repeats
at each MIRU locus (43). This coding system
makes interlaboratory analysis easy to carry out.
In addition, polymorphisms at certain repeat loci
reveal the species, whereas other loci can be used
for epidemiologic typing. Lately, to take advan-
tage of the convenience of this genotyping meth-
odology, a website became available for the analy-
sis of M. tuberculosis MIRU-VNTR genotypes.
Thus, unlike other typing systems this methodol-
ogy now allows for the global molecular epidemio-
logical surveillance of tuberculosis. In principle,
this opportunity should also allow us to gain new
insights into the transmission and population ge-
netics of tuberculosis in a global scale (44).
Genotyping and the population structure
of M. tuberculosis
Until recently, most genotyping methods for the
study of M. tuberculosis were used in defining
differences between individual strains in order to
establish epidemiological l inks of recent
transmission. Now researchers are proving into
the phylogenetic associations amongst distantly
related strains with the use of newer genotyping
methods. For example Supply et al. confirmed the
predominant clonal evolution of M. tuberculosis
with the use of MIRUs (42). The clonal structure
of M. tuberculosis has not only important
implications for molecular epidemiology but also
for phylogeny because clonal species are stable
in space and time. This stability permits the
utilization of molecular epidemiological databases
to track the past and present transmission of the
multiple strains of tuberculosis. This explains the
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renewed interest in defining these phylogenetic
relationships and population structure among dif-
ferent genotype families of M. tuberculosis (17,45).
In addition to MIRUs, deletion analysis by
microarrays is, for the most part, an attractive
approach for studying the phylogeny of M.
tuberculosis strains because in theory it could
provide information about the evolution and
pathogenetic potential of a strain phenotype (1,46).
The goal is to employ the collection of typing
techniques now available to identify individual
strains or clonal groupings of strains with specific
phenotypic characteristics, such as
transmissibility and antigenicity, or resistance to
antimicrobial agents. These strains can then be
subjected to genome wide analysis, using
techniques as microarrays for expression profiling
or detection of genomic deletions, to determine
the genetic basis of these important phenotypes.
This multidisciplinary approach could lead to
important advances in our understanding of the
pathogenesis of human tuberculosis as well as of
mechanisms of drug resistance. For example, by
using a microarray, the genome of a strain can be
assessed to determine if deletions have occurred
relative to a referenced strain. Since these dele-
tions rarely occur independently at exactly the
same chromosomal locus, they can be seen as
unique and irreversible genetic events (47).
Furthermore, the number and distribution of these
deletions can provide a genomic framework, for
constructing phylogenetic associations and to
carry out molecular epidemiology studies (48).
These genotypic techniques have been compared
extensively in terms of its sensitivity, easy to use
and cost (49). Table 1 summarizes some of the
most important character istics of these
techniques.
Molecular epidemiology and
transmission dynamics
Over the past decade, molecular epidemiology
research has been very useful in understanding
outbreaks and transmission dynamics of M.
tuberculosis within different settings. These
studies are based upon the assertion that patients
infected with strains showing identical fingerprints,
termed 'clustered cases', are the result of recent
transmission whereas those infected with a unique
strain are the result of reactivation of strains ac-
Table 1. Comparison of genotypic methods for M. tuberculosis.
Method Repeat Copy Polymorphism Quantity Time Output DiscriminationLimitationAdvantage
sequence number DNA compared with
target  IS6110 RFLP
RFLP IS6110 0-25 High Well weeks Gel Similar High cost Gold
IS6110 grown pattern standard
pure
 culture
RFLP PGRS 26-30 High Well weeks Gel Similar High cost None
PGRS grown pattern
pure
 culture
Spoligotyping DR- 43 High Few <1 Digital Lower Less Low cost
 cluster  grow week code discriminative Easy
pure  to use
culture
VNTR- MIRU 41 High in 12 Few
MIRU MIRU of  grow
 interest pure <1 Digital Diverse None Easy
culture week code  to use
Very
discriminative
Modified from: Kamduma E et al.  J Appl Microbiol 2003;94:781-91.
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quired in the remote past (8). However, this inter-
pretation largely depends on the study question,
the population under study and the genotyping
methods employed. Thus genotyping methods that
are stable could be very useful in global tracking
and evolutionary studies of tuberculosis, while
those that change within years could be used in
the study of outbreaks. So far, most molecular
epidemiology studies have investigated sporadic
outbreaks, cross contamination and the associ-
ated risk factors for recent transmission of the
cases involved. Another purpose of these studies
has been to use molecular epidemiological stud-
ies to help differentiate between reactivation of
tuberculosis and recent transmission. In this part
of the review we will discuss the importance of
molecular epidemiology in the context of tubercu-
losis control.
The impact of HIV on tuberculosis
In addition to the above studies, molecular epide-
miology studies have demonstrated the explosive
potential for tuberculosis to progress to disease
and spread amongst HIV-infected persons (50).
In one study, epidemiological surveillance in a tu-
berculosis control program detected twelve cases
of tuberculosis in a residential facility for persons
with HIV disease. Analysis of isolates by IS6110
RFLP demonstrated that newly acquired
tuberculosis infection in HIV-infected patients
spread readily and progressed to tuberculosis
disease within 3 months of exposure. This study
demonstrated the tremendous impact HIV has on
the pathogenesis and the transmission of M.
tuberculosis.
Furthermore, studies have demonstrated that most
tuberculosis outbreaks associated with HIV
infection occur in hospitals, prisons and longterm
residential facilities in general (51-54). However
these outbreaks in some geographical regions are
now impacting the population in general. In South
Africa, a middle-income country, for example,
sentinel surveys attributed 44% of the total
tuberculosis cases observed to coinfection with
HIV. More alarming is the prediction made by a
simulation model based partly on molecular epi-
demiology data which anticipates that HIV will in-
crease the frequency and severity of tuberculosis
outbreaks beyond what is already expected (55).
Additional molecular epidemiology studies could
help quantitate the actual tuberculosis burden at-
tributed to HIV infection in areas where these two
pandemics converge.
Transmission of drug resistance
Molecular epidemiology has also highlighted the
epidemic spread of drug-resistant strains among
hospitalized patients (12,56-59). Studies
conducted on patients hospitalized in New York
City revealed that more than one third of patients
with multidrug-resistance had clustered RFLP
patterns, suggesting recent transmission of M.
tuberculosis (60). At the peak of the tuberculosis
epidemic in the United States, New York City
accounted for almost one fourth of all cases of
MDR-TB during a 43-month period. Most of these
patients were infected with HIV and were found to
have acquired MDR-TB while hospitalized (59).
Lessons learned from these studies have led to
more rigorous adherence to infection control
policies in hospital settings by National
Tuberculosis Control Programs. As can be inferred
from the description above, this is particularly
important in settings where there are many HIV-
infected persons. In New York City measures
intended to control and prevent tuberculosis were
associated with a 52% decrease in the number of
patients with MDR-TB (61). In this study the DOTS
strategy and hospital infection control policies that
included the physical separation of HIV infected
patients from potential tuberculosis cases has led
to dramatic reductions in tuberculosis rates and
has drastically curtailed the development of drug
resistance.
Transmission and tuberculosis control
The percentage of patients that developed M.
tuberculosis disease as a result of recent
transmission in developed countries was subject
to speculation before the introduction of molecular
epidemiology. The development of molecular
epidemiology tools considerably advanced our
understanding of this subject. Population based
studies in different developed countries demon-
strated that tuberculosis resulting from recent
transmission was higher than the estimated 10%
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predicted by traditional epidemiological studies.
In these countries, 25% to 45% of new cases of
tuberculosis were demonstrated to be the result
of recent transmission (8,62,63). A common
denominator of risk factors was found to be
associated with recent transmission: lower socio-
economic status and HIV coinfection. It was dem-
onstrated that ongoing transmission contributed
to the disease burden at much higher rates than
previously thought and helped gather resources
to strengthen tuberculosis control. These studies
also showed the importance of control efforts
aimed at groups who are at high risk of transmit-
ting or acquiring tuberculosis disease.
In contrast to the studies mentioned above, the
percentage of clustering of tuberculosis isolates
found in Norway and Switzerland was low, 16%
and 17.5% respectively (64,65). In essence this
low level of transmission confirmed that these
countries had effective tuberculosis control
measures in place. In San Francisco, for example,
the rates of clustered tuberculosis cases
decreased significantly both overall and among
persons in high-risk groups after a period during
which tuberculosis control measures were
intensified (66). These studies demonstrate that
molecular epidemiology studies can be used as a
tool to access and monitor the performance of
tuberculosis control programs by targeting
interventions in groups at risk that dispro-
portionately contribute to transmission (67).
However, to date there are still limits to the
widespread use of genotyping to guide
tuberculosis control. These limitations are usually
related to the lack of infrastructure, the complexity
of the techniques used, time required to interpret
results and cost. These limitations could soon be
overcome with advances in the field of PCR base
genotyping techniques. Moreover, there are now
some reference laboratories in developing
countries with genotyping capabilities that want
to support the tuberculosis control program with
these new technologies (68). In theory these tech-
niques could allow the widespread use of molecu-
lar epidemiology as a control measure in the ac-
tivities of national tuberculosis programs in de-
veloping countries.
Contact investigations
In the hope of discovering additional cases, local
tuberculosis control programs in industrialized
countries often evaluate individuals who have been
in contact with infectious tuberculosis patients.
The basic notion of this policy is that contacts
are likely to have been infected by the infectious
case and thus carry the same strain as the index
case. This hypothesis was tested in a study of
index and contact cases with genotyping markers
(69). In this study Behr et al. compared the DNA
fingerprints of indexes and corresponding contacts
with tuberculosis, and found that 30% of the
contacts had different fingerprints. The contacts
were probably infected in the distant past by other
strain, from a third person, and happened to
reactivate their disease during the time the study
was performed. This complexity in transmission
links is also seen in broad population based
molecular epidemiology studies. For example,
RFLP and contact investigation in different settings
demonstrated real epidemiological links in only 5%
to 10% of cases (8,64,70). Also, contrary to the
dogma that tuberculosis is usually acquired
following prolonged exposure to an infectious case,
tracking strains in the community demonstrates
that transmission can occurr after only transient
contact (71).
Transmission in immigrants
The impact of foreign-born individuals on the
epidemiology of tuberculosis is seen as an
important public health issue in developed
countries. The reason is that a large proportion of
tuberculosis cases are diagnosed among
immigrants. In Canada, 80% of the tuberculosis
reported in Montreal and Vancouver occurred
among immigrants (72,73). Moreover between
1986 and 1997 the number of tuberculosis cases
diagnosed in foreign-born persons in the United
States increased by more than 50%, raising the
question of whether or not immigrants do
contribute to active transmission of tuberculosis
to the native population. In regards to this question
in San Francisco, only one out of 43 cases among
immigrants resulted in two secondary cases of
tuberculosis infection among the US born
population (74). Interestingly, in the study, one-
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fifth of the Mexican born patients acquired their
tuberculosis in San Francisco from US born cases.
Another study from the same area showed that
immigrants developed tuberculosis at a much
higher rate due to reactivation, than US born
cases. In this study, native born individual
developed tuberculosis mostly from recent
transmission (75). In the Netherlands and Norway
most recent transmission occurs among foreign-
born individuals of the same nationality and not
between immigrants and the native community
(76,77). In Vancouver, the risk of belonging to a
cluster was higher among immigrants cases than
among Canadian born cases.
Several studies from Europe, Canada, and the
United States showed that the greatest risk for
developing tuberculosis in immigrants occurs in
the first 3 to 5 years upon arrival in the host
country (78,79). One possible reason for these
observations is that recent immigrants usually
encounter poorer social and economical conditions
on arrival in the host country compared to the
conditions they left behind in their native country.
These poor socioeconomic conditions are thought
to result in reactivation of latent tuberculosis and
in some cases active transmission. One could
make a case that in addition to strengthening
tuberculosis control strategies, improving
socioeconomic conditions among recent
immigrants could help to decrease the rates of
tuberculosis. Fur ther awareness of the
transmission dynamics and risk factors of
tuberculosis among group of immigrants will permit
pr iorizing strategies to fur ther decrease
tuberculosis infection.
Reinfection and reactivation
The percentage of reinfection versus recurrence
of tuberculosis has important public health
implications. It was not until molecular
fingerprinting techniques became available that
the exogenous reinfection phenomenon was
convincingly demonstrated to occur (80). This topic
is of extreme importance in developing countries
with high incidence of tuberculosis because ex-
ogenous reinfection can make a significant
contribution to the overall burden of tuberculosis.
Consequently establishing the rates of reinfection
in different settings is imperative for predicting the
effects of control strategies, such as directly ob-
served therapy (DOTS) and treatment of latent in-
fection on the course of the current tuberculosis
epidemic. For example, it is interesting to speculate
the impact DOTS will have on different scenarios
of rates of reinfection. If DOTS rapidly shuts off
transmission, and reinfection is rare, the epidemic
will die off slowly because cases will continue to
appear only through reactivation. On the other
hand, if reactivation is uncommon, the epidemic
will decline relatively quickly as DOTS prevents
new cases by stopping transmission and
reinfection (10). Unfortunately, today there are only
few molecular epidemiology studies that provide
data on reinfection rates and most of them do not
provide the methodological design required to
estimate the incidence on recurrence due to
reinfection (81).
In high incidence settings, particularly those with
high rates of HIV coinfection, it is anticipated that
reinfection plays an important role. This was
apparently the case in a study in Africa where up
to 75% of patients had different fingerprints in their
initial and second episode of disease (82).
However, in another study in the same country
only 2% of cases were found to be due to
reinfection (83). In a population based study in
Spain in a setting with good tuberculosis control
measures, the authors found that 44% of cases
were the result of exogenous reinfection (84). Larger
population based studies are needed to determine
reinfection rates in high incidence countries and
to shed light on important questions of vaccine
development, tuberculosis control and
chemoprophylaxis. Apart from high incidence areas
the problem of recurrence of tuberculosis due to
reinfection is not likely to have important
implications for tuberculosis control programs.
Insights into the pathogenesis of
tuberculosis
The impact of resistant on the pathogenesis
of M. tuberculosis
Experimental models suggest that antibiotic
resistance imposes a biological cost on bacterial
fitness (85). For example, it is thought that the
mechanism by which M. tuberculosis develops
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resistance (genetic alterations mostly by mutations
in the genome) incurs a fitness cost on the micro-
organism. This hypothesis is supported by in vitro
studies, which show that katG (the gene that ac-
tivates isoniazid into its active form) is required
for optimal survival of M. tuberculosis in animal
models (86).
Molecular epidemiology studies carried out in the
Netherlands, Mexico and South Africa in which
less clustering was observed among drug-resistant
strains, suggest that these strains do not spread
at the same rate as drug susceptible strains
(71,83,87). In a more in-depth molecular
epidemiology analysis of clustering over a decade
in San Francisco, the authors assessed the
relative pathogenicity of drug-resistant and drug-
susceptible strains, in a human population by
tracking the strains of M. tuberculosis as they
spread in the community (11). In this study strains
that were resistant to isoniazid either alone or in
combination with other drugs, were found to have
a significantly reduced relative pathogenicity when
compared to susceptible phenotypes. The fitness
cost observed in this study diminished the
epidemiological impact of isoniazid and MDR-TB
resistant phenotypes in this population. However
the resistant organism’s diminished capacity to
cause disease might be offset by delay or
inappropriate treatment because of longer potential
duration of infectiousness. Protracted
infectiousness occurs not infrequently in most
developing countries where drug resistance is not
detected or treated effectively. Thus before
extrapolating the findings of this study to other
settings it will be important to identify the
molecular basis of the attenuation of resistant
mutants and to determine whether similar findings
are occurring under different epidemiological
conditions.
The Beijing genotype and
virulence of M. tuberculosis
A distinct family of M. tuberculosis strains was
associated with more than 350 cases in New York
City and at one point accounted for 25% of all
MDR-TB cases in the United States (88). These
strains were later demonstrated to belong to a
branch of a distinct family and were named the
'Beijing genotype' because of their high prevalence
in the Beijing area of China. The Beijing IS6110
RFLP pattern is not unique and is often difficult to
distinguish from other genotypes. On the other
hand, the spoligotype of the Beijing family is very
much distinctive and straightforward to identify.
In almost every country where it has been studied,
the Beijing phenotype has been found. For
example, with the use of spoligotyping, the Beijing
strains have been associated with transmission
in Asia, Europe (specially, Eastern Europe) and
the Americas (89-95). Its presence has been
detected throughout South East Asia and Hong
Kong, and in one area of study the Beijing
genotype family accounted for 70% of all isolates
(96).
In the Canary Islands, this genotype was appar-
ently initially introduced by an immigrant from Af-
rica and over a period of 4 years this genotype
became the most predominant strain after its in-
troduction (97). In some areas of the world, the
Beijing genotype has been associated with cases
of tuberculosis in young individuals and febrile ill-
ness associated to treatment (98). The associa-
tion of this genotype with a younger age group is
recognized as an indication of ongoing transmis-
sion. Also, reports have found a significant corre-
lation between the Beijing genotype and transmis-
sion of drug resistance (89,94,99). The global dis-
semination and apparent transmissibility in asso-
ciation with drug resistance of this genotype has
alerted to the possibility that these epidemiologi-
cal characteristics of this genotype are a reflec-
tion of an intrinsic biological property unique to
this family. In fact, recently, Rad et al. (100) dem-
onstrated the association of alterations in DNA
repair genes (mutator genes) to the Beijing geno-
type. Mutator genes are presumed to allow the
accumulation of mutations in drug resistant target
genes at higher rates allowing for the development
of resistance. Another example of molecular
mechanisms possibly involved in virulence of drug
resistant strains is the regulation of genes medi-
ated by IS6110. This insertion sequence appears
to be associated with the upregulation of genes
implicated in virulence of Beijing strains and other
clinical strains that have caused MDR-TB out-
breaks (101,102). Further studies with this family
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of strains will reveal the molecular mechanisms
involved in virulence, if in fact these strains are
more virulent than others, and their impact on the
worldwide tuberculosis epidemic. Future molecu-
lar epidemiologic studies may be able to use these
findings to specifically identify virulent strains; this
would allow to individualize control efforts based
on the epidemiological, environmental, host and
bacterial characteristics.
Conclusion
Molecular epidemiology has added a new dimen-
sion to the classical epidemiology of tuberculosis
and greatly improved our understanding of the
transmission dynamics of M. tuberculosis within
different populations. New genotyping methodo-
logies are emerging from genetic manipulation of
bacteria and the complete genome sequence of
M. tuberculosis that are providing us with novel
tools for probing further into the pathogenesis and
epidemiology of tuberculosis. With these new tools
a ground-breaking role for molecular epidemiology
is emerging that studies transmissibility in terms
of environment, host and bacterial characteristics.
However, the remaining challenge is to understand
the transmission dynamics of tuberculosis with
molecular epidemiology techniques in those
countries with the highest burden of disease. The
application of molecular epidemiology in support
of national tuberculosis control programs in high
incidence countries could unleash the true
potential of these methodologies as a research
tool.
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